Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.04)
# 1,398
Out of 4,761 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $163.73 | +6.88% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $79.85 | -24.86% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $27.58 | +153.81% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $109.23 | +5.28% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $84.21 | -5.00% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $2.08 | +3,505.77% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $163.73
Upside: +6.88%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $79.85
Upside: -24.86%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $27.58
Upside: +153.81%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $109.23
Upside: +5.28%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $84.21
Upside: -5.00%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $2.08
Upside: +3,505.77%